A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Thomas Jefferson University
Dana-Farber Cancer Institute
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
University of Nebraska
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Northside Hospital, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Gilead Sciences
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
Gruppo Italiano Malattie EMatologiche dell'Adulto
Georgetown University
University of Illinois at Chicago